Patient Guide: A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 505 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03975647
Status: ACTIVE_NOT_RECRUITING
Condition: HER2-positive Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 505 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Mobile, Alabama
  • Mobile, Alabama
  • Mobile, Alabama
  • • And 502 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily